Glassman Wealth Services Dr Reddys Laboratories LTD Transaction History

Glassman Wealth Services

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$64.27 - $69.9 $128 - $139	2 Added 0.77%	262 $18,000
Q3 2023 Nov 13, 2023	SELL	$61.9 - $72.77 $2,104 - $2,474	-34 Reduced 11.56%	260 $17,000
Q2 2023 Aug 08, 2023	BUY	$53.34 - $63.11 $426 - $504	8 Added 2.8%	294 $18,000
Q1 2023 May 04, 2023	BUY	$51.63 - $56.93 $258 - $284	5 Added 1.78%	286 $16,000
Q4 2022 Feb 06, 2023	BUY	$51.15 - $57.45 $5,063 - $5,687	99 Added 54.4%	281 $14,000
Q3 2022 Nov 09, 2022	BUY	$49.9 - $57.32 $3,143 - $3,611	63 Added 52.94%	182 $10,000
Q2 2022 Aug 04, 2022	BUY	$49.62 - $58.13 $1,389 - $1,627	28 Added 30.77%	119 $7,000
Q1 2022 Apr 14, 2022	BUY	$48.27 - $65.25 $144 - $195	3 Added 3.41%	91 $5,000
Q4 2021 Feb 14, 2022	BUY	$59.5 - $67.25 $4,403 - $4,976	74 Added 528.57%	88 $6,000
Q3 2021 Nov 10, 2021	BUY	$60.19 - $75.29 $842 - $1,054	14 New	14 $1,000

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.61B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.